Acute myocardial infarction and cardiogenic shock in patient with COVID-19
https://doi.org/10.18087/cardio.2021.11.n1534
Abstract
The conditions of the pandemic caused by the novel coronavirus infection (COVID-19) are associated with overloading intensive care units, conversion of hospitals, and changes in routing of patients with acute cardiovascular pathology. At the same time, medical practice is still challenged to provide medical care to patients with acute coronary syndrome (ACS). Patients with COVID-19 and acute myocardial infarction (AMI) are at a higher risk of death while the incidence of this combination of diseases will be growing. This article describes a case of diagnosis and treatment of COVID-19 in a 69-year-old patient who was urgently hospitalized with cardiogenic shock associated with ACS, electrocardiographic signs of complete left bundle branch block, and left ventricular ejection fraction of 19 %. Coronary angiography with stenting was successfully performed in the conditions of extracorporeal membrane oxygenation. The patient received long-term intensive therapy in the intensive care unit followed by symptomatic treatment in the cardiac surgery unit. The patient’s condition gradually improved and he was discharged from the hospital on the 56th day. The strategy of intensive care and active follow-up helped saving life of the patient with COVID-19 and AMI.
Keywords
About the Authors
Yu. A. SchneiderRussian Federation
Dr. Med. Sc., professor, laureate of Burakovsky V.I. awards for achievements in the cardiac surgery, Honored Doctor of Russia, Chief Doctor
V. G. Tsoi
Russian Federation
proxy Chief Doctor by Surgery, Chief of Cardiac Surgery Department №1
M. S. Fomenko
Russian Federation
Cand. Med. Sc., Сardiovascular surgeon of the cardiac surgery department №1
P. A. Shilenko
Russian Federation
Сardiovascular surgeon of the cardiac surgery department №1
I. I. Dimitrova
Russian Federation
Сardiologist of the cardiac surgery department No. 1
A. A. Pavlov
Russian Federation
Cardiovascular surgeon of the cardiac surgery department № 1
A. A. Makarov
Russian Federation
Chief of the intensive care unit No. 1, anesthesiologist
Yu. S. Kalashnikova
Russian Federation
Chief of the intensive care unit No. 2, anesthesiologist
R. N. Boguk
Russian Federation
endovascular surgeon
References
1. Kim HN, Lee JH, Park HS, Yang DH, Jang SY, Bae MH et al. A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock. Journal of Korean Medical Science. 2020;35(27):e258. DOI: 10.3346/jkms.2020.35.e258
2. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic. Journal of the American College of Cardiology. 2020;76(11):1375–84. DOI: 10.1016/j.jacc.2020.04.039
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5
4. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020;46(5):846–8. DOI: 10.1007/s00134-020-05991-x
5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus– Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. DOI: 10.1001/jama.2020.1585
6. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, MarelliBerg FM et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020;116(10):1666–87. DOI: 10.1093/cvr/cvaa106
7. Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB. Cardiac Tamponade Secondary to COVID-19. JACC: Case Reports. 2020;2(9):1326–30. DOI: 10.1016/j.jaccas.2020.04.009
8. Monmeneu JV, Dominguez Mafe E, Andres Soler J, Ventura Perez B, Solsona Caravaca J, Broseta Torres R et al. Subacute perimyocarditis in a young patient with COVID-19 infection. European Heart Journal - Case Reports. 2020;4(FI1):1–3. DOI: 10.1093/ehjcr/ytaa157
9. Meyer P, Degrauwe S, Van Delden C, Ghadri J-R, Templin C. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. European Heart Journal. 2020;41(19):1860. DOI: 10.1093/eurheartj/ehaa306
10. Solano-López J, Sánchez-Recalde A, Zamorano JL. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome. European Heart Journal. 2020;41(32):3106. DOI: 10.1093/eurheartj/ehaa390
11. Peigh G, Leya MV, Baman JR, Cantey EP, Knight BP, Flaherty JD. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. European Heart Journal - Case Reports. 2020;4(FI1):1–6. DOI: 10.1093/ehjcr/ytaa132
12. Ullah W, Saeed R, Sarwar U, Patel R, Fischman DL. COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC: Case Reports. 2020;2(9):1379–82. DOI: 10.1016/j.jaccas.2020.04.008
13. Dominguez-Erquicia P, Dobarro D, Raposeiras-Roubín S, BastosFernandez G, Iñiguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. European Heart Journal. 2020;41(22):2132. DOI: 10.1093/eurheartj/ehaa393
14. Ministry of Health of Russian Federation. Temporary methodical recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-2019). Version 12 (21.09.2021). Av. at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/058/075/original/%D0%92%D0%9C%D0%A0_COVID-19_V12.pdf. 2021.
15. Salian VS, Wright JA, Vedell PT, Nair S, Li C, Kandimalla M et al. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Molecular Pharmaceutics. 2021;18(3):754–71. DOI: 10.1021/acs.molpharmaceut.0c00608
Review
For citations:
Schneider Yu.A., Tsoi V.G., Fomenko M.S., Shilenko P.A., Dimitrova I.I., Pavlov A.A., Makarov A.A., Kalashnikova Yu.S., Boguk R.N. Acute myocardial infarction and cardiogenic shock in patient with COVID-19. Kardiologiia. 2021;61(11):104-107. (In Russ.) https://doi.org/10.18087/cardio.2021.11.n1534